Skip to main content
Clinical Trials/ISRCTN93749377
ISRCTN93749377Completed未知

A preliminary, single-center, prospective, interventional, single-arm study investigating the safety, tolerability and efficacy of Metformin in Romanian adult patients with autosomal dominant polycystic kidney disease

Fundeni Clinical institute0 sites34 target enrollmentStarted: February 25, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
34

Study Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31337351 (added 25/07/2019)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age = 18 years
  • 2. Diagnosis of ADPKD based on unified ultrasonographic Pei-Ravine criteria
  • 3. CKD G1-G5 not on dialysis.

Exclusion Criteria

  • 1. Diabetes mellitus
  • 2. Active infections
  • 3. Pregnant or breastfeeding patients,
  • 4. Known contraindication or allergy to Metformin
  • 5. Receiving renal replacement therapy

Investigators

Sponsor
Fundeni Clinical institute

Similar Trials